Allspring Global Investments
MGNX icon

Allspring Global Investments’s MacroGenics MGNX Stock Holding History

Allspring Global Investments’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,701
Closed -$187K – 2477
2024
Q1 		$187K Sell
12,701
-28,133
-69% -$425K ﹤0.01% 1720
2023
Q4 		$393K Buy
40,834
+15,994
+64% +$111K ﹤0.01% 1554
2023
Q3 		$116K Sell
24,840
-37,868
-60% -$189K ﹤0.01% 1942
2023
Q2 		$335K Buy
62,708
+46,218
+280% +$285K ﹤0.01% 1660
2023
Q1 		$118K Buy
16,490
+7,209
+78% +$43.4K ﹤0.01% 1984
2022
Q4 		$62.3K Buy
9,281
+6,451
+228% +$35.4K ﹤0.01% 2260
2022
Q3 		$9K Buy
+2,830
New +$10.8K ﹤0.01% 2737
2022
Q2 		– Sell
-27,106
Closed -$238K – 2832
2022
Q1 		$238K Buy
27,106
+788
+3% +$8.7K ﹤0.01% 2513
2021
Q4 		$422K Buy
+26,318
New +$495K ﹤0.01% 2365

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's MGNX Position: Q2 2024 in Review

Allspring Global Investments sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 12,701 shares — an estimated $187K sold.

Allspring Global Investments first reported a position in MGNX in Q4 2021 and held it in 9 quarters. The position peaked at $422K in Q4 2021. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Allspring Global Investments reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 12,701 MacroGenics shares in Q2 2024, an estimated $187K.
  • Allspring Global Investments first reported a position in MacroGenics in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's MacroGenics position peaked at $422K in Q4 2021.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.